AstraZeneca PLC

15 Minute Delayed Share Price Glossary Go to Portfolio
Current Chg % Chg Open High Low Volume
2,695.00
-11.50
-0.42% 2,701.00 2,717.50 2,687.00 3.71m

Share Price Chart

label: share priceshare price chart showing price and earning per share against datelabel: earning per share

Broker Recommendation (11 Brokers)

STRONG SELL STRONG BUY
HOLD
Key Figures
Market Cap. £39,239.95m PER (pr) 7.61x EPS Growth (pr) -4.16% ROCE/ROIC 91.37%
Shares in issue 1449.84m PEG (pr) -1.83f DY (pr) 5.38% Net Gearing 47.5%
Company Background
Sector Health
Activities Pharmaceutical company
TIDM AZN
Index FTSE 100, FTSE 350, Eurotop 300, S&P Europe 350, FTSE Eurotop 100, FTSE All Share
Listed LSE - Full

Outlook

(29/10/2009) 3QT: "The company now anticipates sales growth in the range of mid to high single-digits at CER for the full year"
Latest Results
3rd Quarter 30/9/2008 30/9/2009
Turnover £m 13156.47 14919.33
Pre-tax Profit £m 3858.48 5404.58
EPS (Norm Dil.) p 204.09 293.85
Dividend p 95.5 140.65
Notes Figures from 2004 in accordance with IFRS. USD to GBP, 2004: 1.93370, 2005: 1.72030, 2006: 1.96330, 2007: 2.00770, 2008: 1.4582
Investment Ratios
  Co. FTSE Sector Market
PER (pr) x 7.61 10.25 12.71
Dividend Yield (pr) % 5.38 4.96 3.88
PEG (pr) f -1.83 0.86 0.53
ROCE % 91.37 53.11 -6.97
Operating Margin % 34.21 14.64 10.22
EPS Growth (pr) % -4.16 4.86 12.48
EV/EBITDA x 5.52 7.40 6.57
Net Gearing % 47.52 94.63 158.93
Net Tangible Asset Value PS p -297.77 -1.06 1.37
Price to Tangible Book Value (PTBV) x -9.09 -8.13 0.74
Price to Cashflow (PCF) x 6.45 8.54 9.21
Price to Sales Ratio (PSR) x 1.82 2.61 2.05
Definitions | Disclaimer
Data provided by Morningstar.
© Copyright 2009 Morningstar. All rights reserved. Please read our Terms of Use and Privacy Policy.